Jefferies Group LLC Regeneron Pharmaceuticals, Inc. Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $14.9 Million - $20.1 Million	-27,236 Closed	0 $0
Q1 2022 Sep 21, 2023	BUY	$595.12 - $698.43 $11.4 Million - $13.4 Million	19,197 Added 238.8%	27,236 $19 Million
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $11.4 Million - $13.4 Million	19,197 Added 238.8%	27,236 $19 Million
Q4 2021 Sep 21, 2023	SELL	$543.48 - $670.97 $87,500 - $108,026	-161 Reduced 1.96%	8,039 $5.08 Million
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $87,500 - $108,026	-161 Reduced 1.96%	8,039 $5.08 Million
Q3 2021 Sep 21, 2023	SELL	$574.03 - $680.96 $5.4 Million - $6.4 Million	-9,404 Reduced 53.42%	8,200 $4.96 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $5.4 Million - $6.4 Million	-9,404 Reduced 53.42%	8,200 $4.96 Million
Q2 2021 Sep 21, 2023	BUY	$472.8 - $558.54 $3.34 Million - $3.94 Million	7,056 Added 66.89%	17,604 $9.83 Million
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $3.34 Million - $3.94 Million	7,056 Added 66.89%	17,604 $9.83 Million
Q1 2021 Sep 21, 2023	SELL	$446.73 - $548.2 $2.82 Million - $3.46 Million	-6,308 Reduced 37.42%	10,548 $4.99 Million
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $2.82 Million - $3.46 Million	-6,308 Reduced 37.42%	10,548 $4.99 Million
Q4 2020 Sep 21, 2023	BUY	$478.3 - $607.98 $8.06 Million - $10.2 Million	16,856 New	16,856 $8.14 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $3.44 Million - $4.37 Million	7,183 Added 74.26%	16,856 $8.14 Million
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $1.57 Million - $1.9 Million	2,886 Added 42.52%	9,673 $5.42 Million
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $3.32 Million - $4.34 Million	6,740 Added 14340.43%	6,787 $4.23 Million
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $5,042 - $7,416	15 Added 46.88%	47 $23,000
Q4 2019 Feb 13, 2020	SELL	$274.13 - $376.51 $1.29 Million - $1.77 Million	-4,693 Reduced 99.32%	32 $12,000
Q3 2019 Nov 13, 2019	SELL	$273.46 - $318.39 $353,583 - $411,678	-1,293 Reduced 21.49%	4,725 $1.31 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $1.8 Million - $2.5 Million	6,018 New	6,018 $1.88 Million
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $185,372 - $222,478	-552 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $1 Million - $1.16 Million	-2,850 Reduced 83.77%	552 $223,000
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $516,833 - $626,501	1,816 Added 114.5%	3,402 $1.17 Million
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $1.54 Million - $1.92 Million	-4,870 Reduced 75.43%	1,586 $546,000
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $2.28 Million - $2.99 Million	6,357 Added 6421.21%	6,456 $2.43 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $42,706 - $49,896	99	99 $44,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account